Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/173662 |
Resumo: | OBJECTIVES: We aimed to evaluate the effectiveness of microablative fractional radiofrequency (MAFRF) in the non-hormonal treatment of genitourinary syndrome of menopause. METHODS: We examined the cases of 55 postmenopausal women before and after treatment with regard to their vaginal health index (VHI), vaginal microbiota, vaginal pH, and cell maturation. Three applications of MAFRF were performed in the vagina/vaginal introitus. During the treatment, six vaginal smears were obtained and stained with the Papanicolaou stain for determining the degree of cell maturation and with Gram stain for classification of vaginal flora, as per the criteria of Spiegel and Amsel. For vaginal pH determination, pH indicator strips were applied against the vaginal wall. Statistical analysis was performed using SPSS for Windows (version 17.0). Data were reported as mean±standard deviation. The differences were analyzed using the statistical method of generalized estimation equations with autoregressive correlation structure ‘‘1’’ and robust standard errors. RESULTS: The mean age was 59.8±4.2 years, and the mean time of menopause was 15.4±4.5 years. After treatment, there was an increase in the percentage of Lactobacillus spp. (po0.001). Consequently, there was a progressive decrease in vaginal pH during the treatment (po0.001). Regarding cell maturation, there was a decrease in the percentage of parabasal cells (p=0.001) and an increase in the rate of superficial cells (po0.001). Additionally, there was an improvement in the VHI index. The mean VHI values before and after treatment were 13.2±5.6 and 22.5±3.7, respectively (po0.001). CONCLUSION: MAFRF treatment is well tolerated and leads to improvement in the vaginal microenvironment. |
id |
USP-19_6e314f1d4cd8c994dd55cf711ee5cb25 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/173662 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal womenMenopauseRadiofrequencyDyspareuniaOrgasmTherapeuticsOBJECTIVES: We aimed to evaluate the effectiveness of microablative fractional radiofrequency (MAFRF) in the non-hormonal treatment of genitourinary syndrome of menopause. METHODS: We examined the cases of 55 postmenopausal women before and after treatment with regard to their vaginal health index (VHI), vaginal microbiota, vaginal pH, and cell maturation. Three applications of MAFRF were performed in the vagina/vaginal introitus. During the treatment, six vaginal smears were obtained and stained with the Papanicolaou stain for determining the degree of cell maturation and with Gram stain for classification of vaginal flora, as per the criteria of Spiegel and Amsel. For vaginal pH determination, pH indicator strips were applied against the vaginal wall. Statistical analysis was performed using SPSS for Windows (version 17.0). Data were reported as mean±standard deviation. The differences were analyzed using the statistical method of generalized estimation equations with autoregressive correlation structure ‘‘1’’ and robust standard errors. RESULTS: The mean age was 59.8±4.2 years, and the mean time of menopause was 15.4±4.5 years. After treatment, there was an increase in the percentage of Lactobacillus spp. (po0.001). Consequently, there was a progressive decrease in vaginal pH during the treatment (po0.001). Regarding cell maturation, there was a decrease in the percentage of parabasal cells (p=0.001) and an increase in the rate of superficial cells (po0.001). Additionally, there was an improvement in the VHI index. The mean VHI values before and after treatment were 13.2±5.6 and 22.5±3.7, respectively (po0.001). CONCLUSION: MAFRF treatment is well tolerated and leads to improvement in the vaginal microenvironment.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2020-08-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/17366210.6061/clinics/2020/e1750Clinics; Vol. 75 (2020); e1750Clinics; v. 75 (2020); e1750Clinics; Vol. 75 (2020); e17501980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/173662/162766https://www.revistas.usp.br/clinics/article/view/173662/162767Copyright (c) 2020 Clinicsinfo:eu-repo/semantics/openAccessSarmento, Ayane CristineFernandes, Fabíola SephoraMarconi, CamilaGiraldo, Paulo CésarEleutério-Júnior, JoséCrispim, Janaina C.Gonçalves, Ana Katherine2020-08-14T21:51:04Zoai:revistas.usp.br:article/173662Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2020-08-14T21:51:04Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women |
title |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women |
spellingShingle |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women Sarmento, Ayane Cristine Menopause Radiofrequency Dyspareunia Orgasm Therapeutics |
title_short |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women |
title_full |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women |
title_fullStr |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women |
title_full_unstemmed |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women |
title_sort |
Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women |
author |
Sarmento, Ayane Cristine |
author_facet |
Sarmento, Ayane Cristine Fernandes, Fabíola Sephora Marconi, Camila Giraldo, Paulo César Eleutério-Júnior, José Crispim, Janaina C. Gonçalves, Ana Katherine |
author_role |
author |
author2 |
Fernandes, Fabíola Sephora Marconi, Camila Giraldo, Paulo César Eleutério-Júnior, José Crispim, Janaina C. Gonçalves, Ana Katherine |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Sarmento, Ayane Cristine Fernandes, Fabíola Sephora Marconi, Camila Giraldo, Paulo César Eleutério-Júnior, José Crispim, Janaina C. Gonçalves, Ana Katherine |
dc.subject.por.fl_str_mv |
Menopause Radiofrequency Dyspareunia Orgasm Therapeutics |
topic |
Menopause Radiofrequency Dyspareunia Orgasm Therapeutics |
description |
OBJECTIVES: We aimed to evaluate the effectiveness of microablative fractional radiofrequency (MAFRF) in the non-hormonal treatment of genitourinary syndrome of menopause. METHODS: We examined the cases of 55 postmenopausal women before and after treatment with regard to their vaginal health index (VHI), vaginal microbiota, vaginal pH, and cell maturation. Three applications of MAFRF were performed in the vagina/vaginal introitus. During the treatment, six vaginal smears were obtained and stained with the Papanicolaou stain for determining the degree of cell maturation and with Gram stain for classification of vaginal flora, as per the criteria of Spiegel and Amsel. For vaginal pH determination, pH indicator strips were applied against the vaginal wall. Statistical analysis was performed using SPSS for Windows (version 17.0). Data were reported as mean±standard deviation. The differences were analyzed using the statistical method of generalized estimation equations with autoregressive correlation structure ‘‘1’’ and robust standard errors. RESULTS: The mean age was 59.8±4.2 years, and the mean time of menopause was 15.4±4.5 years. After treatment, there was an increase in the percentage of Lactobacillus spp. (po0.001). Consequently, there was a progressive decrease in vaginal pH during the treatment (po0.001). Regarding cell maturation, there was a decrease in the percentage of parabasal cells (p=0.001) and an increase in the rate of superficial cells (po0.001). Additionally, there was an improvement in the VHI index. The mean VHI values before and after treatment were 13.2±5.6 and 22.5±3.7, respectively (po0.001). CONCLUSION: MAFRF treatment is well tolerated and leads to improvement in the vaginal microenvironment. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-08-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/173662 10.6061/clinics/2020/e1750 |
url |
https://www.revistas.usp.br/clinics/article/view/173662 |
identifier_str_mv |
10.6061/clinics/2020/e1750 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/173662/162766 https://www.revistas.usp.br/clinics/article/view/173662/162767 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Clinics info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Clinics |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/xml |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; Vol. 75 (2020); e1750 Clinics; v. 75 (2020); e1750 Clinics; Vol. 75 (2020); e1750 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1800222765184188416 |